PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical
News

Scottish Medicines Consortium agrees to use of Rinvoq

Therapy will now treat adults across Scotland with moderate rheumatoid arthritis. AbbVie has announced that the Scottish Medicines Consortium (SMC) has accepted R...
Continue Reading →
News

Novartis joins Cancer Research UK on rare cancers study

DETERMINE trial aims to discover if current treatments could benefit patients with other cancer types. Cancer Research UK’s DETERMINE trial – which was launched i...
Continue Reading →
News

Kidney Research UK concerned by NICE process

Organisation believes the guidance would leave renal patients with no effective treatment outside the hospital. Kidney Research UK has responded to the National I...
Continue Reading →
News

Positive results for Amphera’s MesoPher cell therapy

Treatment demonstrated significant survival data in addition to a sustained safety profile. Amphera – a company developing MesoPher cell therapy to treat cancer –...
Continue Reading →
News

Catalent completes cell therapy manufacturing facilities in Belgium

The facility represents one of the largest commercial-scale operations in the world. Catalent – a company aiming to boost the supply of better patient treatments ...
Continue Reading →
News

Novadip reveals results from severe bone non-union trial

The study involves candidate NVD-003 and the treatment of lower limb trauma. Novadip Biosciences – a company developing regenerative tissue products to accelerate...
Continue Reading →
News

CPHI Frankfurt returns to pre-pandemic strength as pharma industry booms again

In-person visitor numbers rebound sharply, with record C-Suite attendance and the largest-ever online presence. The global pharma industry was out in full for...
Continue Reading →
News

LEO Pharma reveal positive results from delgocitinib research

Phase 3 clinical trial focuses on adults with moderate-to-severe chronic hand eczema. LEO Pharma has announced positive results from its DELTA 1 trial – the first...
Continue Reading →
News

Spago Nanomedical begins endometriosis study

The clinical trial has received regulatory approval and involves endometriosis candidate SN132D. Spago Nanomedical has announced that it has received regulatory a...
Continue Reading →
News

Valneva shares positive chikungunya vaccine results

99% of participants retained very high neutralising antibody levels 12 months after treatment. Valneva has announced positive antibody persistence data twelve mon...
Continue Reading →

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026